Yoshimura et al. identified CD200 and CD200R1 as the differentially expressed biomarkers of lung cancer [66], while Supplementary Figure S5 shows that the two strong dark biomarkers have similar or higher expression levels compared to CD200 and CD200R1. Here, CD200R1 is linked to lung carcinoma.